Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NR3C2”

113 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 113 results

Early research (Phase 1)Not Yet RecruitingNCT07795762
What this trial is testing

Eplerenone and IOP in Healthy Adults

Who this might be right for
Intraocular Pressure (IOP)Healthy Adult
University of Florida 30
Large-scale testing (Phase 3)Study completedNCT02807987
What this trial is testing

Study of CS-3150 in Combination With ARB or ACE Inhibitor in Hypertensive Patients With Moderate Renal Impairment

Who this might be right for
Hypertension With Moderate Renal Impairment
Daiichi Sankyo Co., Ltd. 58
Testing effectiveness (Phase 2)Looking for participantsNCT07238400
What this trial is testing

Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia

Who this might be right for
Hypertension
Massachusetts General Hospital 90
Not applicableStudy completedNCT03062150
What this trial is testing

Mineralocorticoid Receptor, NMDA Receptor and Cognitive Function in Depression

Who this might be right for
Major Depression
Charite University, Berlin, Germany 232
Not applicableNot Yet RecruitingNCT07775482
What this trial is testing

Finerenone for AKI: a Multicenter, Randomized, Placebo-Controlled Feasibility Pilot Trial

Who this might be right for
Acute Kidney InjuryRenal Insufficiency,ChronicKidney Diseases
Jean-Maxime Côté 72
Large-scale testing (Phase 3)Study completedNCT01319344
What this trial is testing

Effect of Eplerenone on Endothelial Function in Metabolic Syndrome

Who this might be right for
Metabolic SyndromeEndothelial Dysfunction
University of Erlangen-Nürnberg Medical School 42
Large-scale testing (Phase 3)Study completedNCT02040441
What this trial is testing

Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria

Who this might be right for
Diabetic NephropathyDiabetic Retinopathy
Peter Rossing 1,777
Large-scale testing (Phase 3)Study completedNCT02807974
What this trial is testing

Study of CS-3150 in Hypertensive Patients With Type 2 Diabetes and Albuminuria

Who this might be right for
Hypertension
Daiichi Sankyo Co., Ltd. 51
Early research (Phase 1)Ended earlyNCT03682497
What this trial is testing

Study in HFpEF Patients to Compare the Effect of AZD9977 and Spironolactone on Serum Potassium

Who this might be right for
Heart Failure
AstraZeneca 68
Early research (Phase 1)Study completedNCT06649409
What this trial is testing

Evaluation of Vamorolone Mineralocorticoid Receptor Antagonism in Healthy Subjects

Who this might be right for
Pharmacodynamic
Santhera Pharmaceuticals 30
Testing effectiveness (Phase 2)Study completedNCT05884866
What this trial is testing

Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Chronic Kidney Disease.

Who this might be right for
Chronic Renal FailureMechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte HomeostatisChronic Kidney Disease Stage 3+1 more
Klinikum Nürnberg
Early research (Phase 1)Study completedNCT06979388
What this trial is testing

Investigate the Effect of Food on Balcinrenone/Dapagliflozin Pharmacokinetics in Fed and Fasted State and Pharmacokinetics of Balcinrenone When Dosed With a P-gp Inhibitor in Healthy Participants.

Who this might be right for
Healthy Participants
AstraZeneca 14
Testing effectiveness (Phase 2)Study completedNCT01691053
What this trial is testing

Mineralocorticoid Receptor Antagonists in End Stage Renal Disease

Who this might be right for
End Stage Renal Disease / Hemodialysis
Wuerzburg University Hospital 118
Not applicableUnknownNCT05262660
What this trial is testing

The Long-term Effect of SAAE and Medical Treatment for Primary Aldosteronism

Who this might be right for
Primary Aldosteronism
First Affiliated Hospital of Chengdu Medical College 400
Early research (Phase 1)Study completedNCT04798222
What this trial is testing

Study to Assess the Bioavailability of Different Formulations of AZD9977 and Dapagliflozin and Influence of Food in Selected Formulations in Healthy Volunteers

Who this might be right for
Heart Failure
AstraZeneca 20
Early research (Phase 1)Study completedNCT01648998
What this trial is testing

Fludrocortisone and Information Processing in Healthy Volunteers

Who this might be right for
Depression
Leiden University Medical Center 40
Not applicableStudy completedNCT03789357
What this trial is testing

Prevalence of Primary Aldosteronism in Patients With Stroke

Who this might be right for
Primary AldosteronismStroke
Changi General Hospital 300
Early research (Phase 1)Study completedNCT01103245
What this trial is testing

Aldosterone and the Metabolic Syndrome

Who this might be right for
Metabolic DiseasesDiabetes MellitusEndocrine System Diseases+1 more
Vanderbilt University Medical Center 69
Post-approval studies (Phase 4)Study completedNCT03476616
What this trial is testing

Antihypertensive Pharmacological Therapy With Mineralocorticoid Receptor Antagonists in Obese Hypertensive Patients

Who this might be right for
HypertensionObesity
Hippocration General Hospital 198
Post-approval studies (Phase 4)Not Yet RecruitingNCT07523867
What this trial is testing

Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study

Who this might be right for
Heart FailureDiabetic Kidney DiseaseHyperkalemia
Hospital de Messejana Dr. Carlos Alberto Studart Gomes 60
Next Page
103